You are here

Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal Infections

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Haidari, Athens, 124 62 Greece
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Complicated Intra-Abdominal Infection
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- A recorded primary diagnosis of a complicated intra-abdominal. infection (cIAI) and a
procedure involving a laparotomy, laparoscopy, or percutaneous drainage of an
intra-abdominal abscess The study will be a prospective, multi-centre, epidemiological
study of patients (aged > 18 years) diagnosed with a complicated intra-abdominal
infection AND who received a procedure involving laparotomy/laparoscopy or
percutaneous drainage of an intra-abdominal abscess. cIAI's will include the following
conditions/ diagnoses:

- Gastric ulcer with perforation;

- Gastric ulcer with hemorrhage and perforation;

- Duodenal ulcer with perforation;

- Duodenal ulcer with hemorrhage and perforation;

- Peptic ulcer with perforation;

- Peptic ulcer with hemorrhage and perforation;

- Gastrojejunal ulcer with perforation;

- Gastrojejunal ulcer with hemorrhage and perforation;

- Acute appendicitis with generalized peritonitis;

- Acute appendicitis with peritoneal abscess;

- Peritonitis;

- Abscess of intestine;

- Fistula of intestine, excluding rectum and anus;

- Ulceration of intestine;

- Perforation of intestine;

- Abscess of liver; or

- Acute cholecystitis with perforation.

The initial antibiotic regimen will be defined as all IV antibiotics newly received either
on the day immediately prior to laparotomy or laparoscopy or percutaneous drainage of an
intra-abdominal abscess, or on the day of these procedures, given that the use of these
procedures prior to initiation of IV antibiotic regimens in complicated IAIs , which is
increasingly common, is likely reflective of prophylaxis.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients not signing an informed consent form.

- Patients participating in another interventional study.

NCT00929643
Pfizer
Completed
Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal Infections

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia, Ventilator Associated Pneumonia
NCT03329092
All Genders
18+
Years
Multiple Sites
Complicated Urinary Tract Infection, Complicated Intra-abdominal Infection
NCT01644643
All Genders
18+
Years
Multiple Sites
Community Acquired Bacterial Pneumonia, Complicated Intra-Abdominal Infection
NCT00914888
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now